News
HACRO Joins the 18th Greece Race for the Cure® in Support of Breast Cancer Awareness
For yet another year, HACRO - Hellenic Association of CROs proudly participated in the 18th Greece Race for the Cure®, held on Sunday, October 4, in Athens. HACRO members joined more than 58,000 participants in this major event, highlighting the importance of prevention, awareness, support, and solidarity in the fight against breast cancer. The Greece…
Previous posts
HACRO President Evangelia (Lia) Koraki Speaks at the EUPATI Greece Patient Academy
Patient information and education are essential prerequisites for their meaningful participation in clinical research. As part of the three-day educational programme of the EUPATI…
HACRO and the National and Kapodistrian University of Athens Join Forces to Educate the Next Generation of Clinical Research Professionals
The Memorandum of Understanding between HACRO and the MSc Programme "Clinical Trials: Design and Conduct" of Medical School of National and Kapodistrian University of…
Clinical Research in the Spotlight at the Delphi Economic Forum — A HACRO Initiative
Strong messages on enhancing competitiveness and attracting investment to Greece through targeted initiatives and a unified direction across all stakeholders Athens, April 27, 2026…
EOF Conference: “The Role of EOF in Shaping Pharmaceutical Policy – The Next Steps”
HACRO participated in the scientific conference organized by the National Organization for Medicines (EOF) on Wednesday, February 4, 2026, titled “The Role of EOF…
The Greek Patients’ Association Launches Greece’s First EUPATI Patient Academy
The Greek Patients’ Association launches the first EUPATI Patient Academy in Greece (https://academy.greekpatient.gr/), a comprehensive educational program aimed at strengthening the role of patients…
Three dynamic tools by Rare Diseases Greece: Empowering patients with Rare Diseases
Rare Diseases Greece presents three groundbreaking, interactive tools that offer valuable support to individuals living with rare diseases in Greece. These tools aim to…
EMA’s New Clinical Trial Map: Transforming Access and Transparency in European Clinical Research
The new Clinical Trial Map, made available by the European Medicines Agency (EMA) through the public online platform CTIS, represents a particularly significant advancement…